AQUALUNG THERAPEUTICS CORP. Receives NIH Approval to Advance to IND-Enabling Studies Via the STTR Fastrack Phase II Award for Development of A Novel Anti-Inflammatory Therapeutic Antibody for ARDS and the Critically Ill
New Hope for Treating Major Cause of COVID-19 Deaths Even before the COVID-19 Pandemic, each…
Four Inc. Secures Spot on Washington Technology’s Top 100 Government Contractors List for 11th Consecutive Year
Tat Hong Equipment Service Co., Ltd. Announces 2025/26 Annual Results